No hasty solutions for African swine fever

African swine fever vaccines could pose risk of causing disease and spreading the virus further.

Back to publications

Publication

Contributors

Gavier-Widén D, Ståhl K, Dixon L

Year

2020

Journal

Science

Volume

367

Issue

6478

Pages

622-624

Associated groups

African swine fever virus

African Swine Fever Virus

Associated viruses

African swine fever virus

Egg candling

18 September 2026

Researchers find potential new route to faster IBV poultry vaccines

Pirbright study may reduce reliance on embryonated hens’ eggs Scientists at The Pirbright Institute have identified a promising new route to develop faster, more adaptable vaccines against infectious bronchitis virus (IBV), one of the poultry industry's most economically significant diseases…

Sheeps in hay

15 September 2026

Pirbright welcomes vet-led BTV diagnosis

‘Sensible step’ for government testing Changes to testing for bluetongue virus (BTV) have been welcomed by The Pirbright Institute. The government has announced new measures to cut waiting times for farmers and give them quicker confirmation of suspected cases, allowing them to protect livestock…

04 September 2026

Cell growth platform advances African Swine Fever research

Researchers at The Pirbright Institute have contributed to the development of a new method to generate pig immune cells on demand, providing a valuable platform for research into African swine fever virus (ASFV). The approach enables scientists to produce macrophages - the immune cells targeted by…

Sheep

03 September 2026

Pirbright reinforces BTV response

Scientists from The Pirbright Institute have been engaging with farmers and vets as the Pirbright Institute reinforces its response to bluetongue virus. Over 750 UK cases of serotype 3 (BTV-3) have been reported to date in the 2026-27 bluetongue season. More than 650 are in England, with the South…